BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2872705)

  • 1. N,N'-diallylbarbital potentiation of drug-induced sleep and motor incoordination.
    Tateoka Y; Yamamoto I; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):17-28. PubMed ID: 2872705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prolonging effect of N,N'-diallylpentobarbital on the drug-induced sleep and motor incoordination.
    Yamamoto I; Tateoka Y; Watanabe K; Nabeshima T; Fontenot HJ; Ho IK
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):209-19. PubMed ID: 4081315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of N-allyl,N'-methyl-barbital and N-allylmethyprylon in mice.
    Yamamoto I; Tateoka Y; Kimura T; Yamazaki F; Hamajima K; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):191-9. PubMed ID: 2878477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
    Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the structure-activity relationship of allyl substituted oxopyrimidines searching for the novel antagonist or agonist of barbiturates to the sleep mechanism based on the uridine receptor theory--barbituric acid to uridine (part I)].
    Yamamoto I
    Yakugaku Zasshi; 2005 Jan; 125(1):73-120. PubMed ID: 15635282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central depressant activities of N3-allyluridine and N3-allylthymidine.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):321-32. PubMed ID: 3738212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of the neuropharmacology of phenylurea.
    Zirvi KA; Fakouhi T
    Arzneimittelforschung; 1977; 27(6):1194-8. PubMed ID: 578440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of N,N'-diallylpentobarbital potentiation of pentobarbital-induced sleep in mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):173-85. PubMed ID: 3659568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant, anxiolytic, and sedative properties of the roots of Nauclea latifolia Smith in mice.
    Ngo Bum E; Taiwe GS; Moto FC; Ngoupaye GT; Nkantchoua GC; Pelanken MM; Rakotonirina SV; Rakotonirina A
    Epilepsy Behav; 2009 Aug; 15(4):434-40. PubMed ID: 19560975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedative and anticonvulsant activities of styrax after oral and intranasal administration in mice.
    Guo J; Duan JA; Tang Y; Li Y
    Pharm Biol; 2011 Oct; 49(10):1034-8. PubMed ID: 21428734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of isoproturon, a substituted phenylurea herbicide, in mice.
    Sarkar SN; Gupta PK
    Indian J Exp Biol; 1993 Dec; 31(12):977-81. PubMed ID: 8112777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
    Assi AA
    J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticonvulsant and CNS activity of N-butyryl-N-butylurea in mice.
    Dar MS; Zirvi K; Fakouhi T
    Farmaco Sci; 1979 Nov; 34(11):936-44. PubMed ID: 553825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea.
    Tantisira B; Tantisira MH; Patarapanich C; Sooksawate T; Chunngam T
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):151-64. PubMed ID: 9344228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavioral effects of flutoprazepam (KB-509) and its metabolites].
    Ueki S; Sukamoto T; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Suwandi D; Shibata K; Takano M; Sato Y
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):15-30. PubMed ID: 6890927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the neuropharmacology of tert-butylurea in mice.
    Dar MS
    Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):103-15. PubMed ID: 1267534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of behavioral effects of pentylenetetrazol by the neuroactive steroid ganaxolone.
    Beekman M; Ungard JT; Gasior M; Carter RB; Dijkstra D; Goldberg SR; Witkin JM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):868-77. PubMed ID: 9495844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological effects of melatonin in mouse and rat.
    Sugden D
    J Pharmacol Exp Ther; 1983 Dec; 227(3):587-91. PubMed ID: 6655558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.